Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study
Open Access
- 5 May 2001
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 84 (9), 1179-1184
- https://doi.org/10.1054/bjoc.2001.1784
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Revisions in the International System for Staging Lung CancerChest, 1997
- Phase II studies of gemcitabine for non-small cell lung cancer in Japan.1997
- Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1997
- Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1997
- Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial.Journal of Clinical Oncology, 1996
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC)Annals of Oncology, 1995
- Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.Journal of Clinical Oncology, 1995
- Gemcitabine: metabolism, mechanisms of action, and self-potentiation.1995
- Paclitaxel (Taxol)New England Journal of Medicine, 1995